Filing Details
- Accession Number:
- 0001232524-15-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-05 18:51:57
- Reporting Period:
- 2015-03-03
- Filing Date:
- 2015-03-05
- Accepted Time:
- 2015-03-05 18:51:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1267490 | J Karen Wilson | Connaught House, 1 Burlington Rd, Fl. 4 Dublin 4 L2 | Svp, Finance & Pao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2015-03-03 | 2,598 | $176.27 | 21,046 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2015-03-04 | 152 | $46.83 | 21,198 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2015-03-04 | 5,007 | $27.46 | 26,205 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Incentive Stock Option (right to buy) | Disposition | 2015-03-04 | 5,007 | $0.00 | 5,007 | $27.46 |
| Ordinary Shares | Incentive Stock Option (right to buy) | Disposition | 2015-03-04 | 152 | $0.00 | 152 | $46.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-03-09 | No | 4 | M | Direct | |
| 2,896 | 2022-08-08 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.15 to $176.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The ordinary shares subject to this option fully vested as of February 7, 2015.
- This incentive stock option is part of an option granted on August 9, 2012 that consisted of this incentive stock option exercisable for 3,048 ordinary shares and a nonstatutory stock option exercisable for 26,952 ordinary shares. As of the date of this report, the remaining ordinary shares subject to this incentive stock option will vest with respect to 761 shares in equal monthly installments from March 9, 2015 to December 9, 2015 and with respect to 2,135 shares in equal monthly installments from January 9, 2016 to August 9, 2016.
Billionaire Hedge Funds
